ライフサイエンスコーパス: anal canal

1 s with AJCC stages I to III carcinoma of the anal canal.

2 ncer (AJCC) stages I to III carcinoma of the anal canal.

3 al margin is very different from that of the anal canal.

4 iddle part of the vagina, perineal body, and anal canal.

5 poor-prognosis squamous cell cancers of the anal canal.

6 ith localized squamous cell carcinoma of the anal canal.

7 nd sensory perception between the rectum and anal canal.

8 red treatment of epidermoid carcinoma of the anal canal.

9 ng, discomfort, and tissue prolapse from the anal canal.

10 y in advanced squamous cell carcinoma of the anal canal.

11 l muscle cells, but do not contribute to the anal canals.

12 The prevalence of HPV infection in the anal canal (12.0%) was similar among MSW in each city (P

13 V-16 was the most prevalent type in both the anal canal (13.2% of women) and the cervix (5.1%).

14 patients with squamous cell carcinoma of the anal canal (ACC), disease stage influences treatment pla

15 sease, pathology of the tissue lining of the anal canal, affects approximately 10 million individuals

16 asic non-painful distension of the rectum or anal canal, alternating with rest periods, without stimu

17 k human papillomavirus (HR-HPV) types in the anal canal among human immunodeficiency virus-positive m

18 ping for HPV was conducted on cells from the anal canal among men who have sex with women (MSW) and m

19 y to the right, positioned at the top of the anal canal and extending into the rectum, measuring appr

20 ation events leading to the formation of the anal canal and parts of the urogenital tract.

21 curately located the implant relative to the anal canal and pelvic floor in each patient.

22 ctum maximum pressure, anal canal PV); push (anal canal and rectum maximum pressure).

23 essure asymmetry); long squeeze (PV); cough (anal canal and rectum maximum pressure, anal canal PV);

24 The imaging device is inserted into the anal canal and the intraluminal surface is digitally pho

25 is an abnormal tract connection between the anal canal and the surrounding skin of the perineum, wit

26 t the perineal/perianal region, 42.4% in the anal canal, and 48.0% at any site.

27 ence of squamous cell carcinoma of the anus, anal canal, and anorectum (SCCA) has increased over time

28 ne, the boundary between the upper and lower anal canal, and may cause rectal bleeding, discomfort, a

29 stically significant for the scrotum, semen, anal canal, and perianal area.

30 ative IP incidence over 36 months (excluding anal canal; any 9vHPV type) was higher among MSM versus

31 Carcinomas of the anal canal are strongly associated with the human papill

32 a hand-sewn anastomosis of the pouch to the anal canal at the dentate line.

33 gh among young sexually active MSM, with the anal canal being the most common site of infection.

34 for colonoscopy, which reveals a mass in the anal canal; biopsy of the mass shows squamous cell carci

35 Although most patients with anal canal cancer are cured with sphincter-preserving, n

36 To report a multicenter experience treating anal canal cancer patients with concurrent chemotherapy

37 the majority of patients with poor-prognosis anal canal cancer.

38 st that concurrent chemotherapy and IMRT for anal canal cancers is effective and tolerated favorably

39 Patients with previously untreated anal canal cancers with T3 or T4 tumors and/or extensive

40 y (RCT) is the standard for locally advanced anal canal carcinoma (LAACC).

41 platin and radiotherapy in 682 patients with anal canal carcinoma enrolled between October 31, 1998,

42 In this population of patients with anal canal carcinoma, cisplatin-based therapy failed to

43 survival (DFS) or overall survival (OS) for anal canal carcinoma.

44 ouracil and radiotherapy in the treatment of anal canal carcinoma.

45 preferred primary therapy for patients with anal canal carcinoma; however, the 5-year disease-free s

46 infection at external genital sites and the anal canal compared to men from Australia.

47 splatin and Radiotherapy in Carcinoma of the Anal Canal], concurrent chemoradiation (CCR) with fluoro

48 CH was performed without pedicle ligature or anal-canal dressing, and a diclofenac suppository was ad

49 For patients with carcinoma of the anal canal, external-beam irradiation with 5-fluorouraci

50 hoid prolapse is classified as grade I (into anal canal), grade II (beyond the anus with spontaneous

51 management of squamous cell carcinoma of the anal canal has undergone profound change over the last 3

52 Anal canal HPV infection is commonly found among MSW, an

53 Anal canal HPV prevalence was 12.2% among 1305 MSW and 4

54 ong men suggests a need to better understand anal canal human papillomavirus (HPV) infection among hu

55 ng endoscope can be used for circumferential anal canal imaging and is safe for clinical use.

56 er preserving the transitional mucosa of the anal canal improves outcomes.

57 HR-HPV types were detected in the anal canal in 148 women (47.6%) and in the cervix in 82

58 than did control patients (mean arc angle of anal canal involved, 220 degrees vs 60 degrees ; P < .00

59 treatment of patients with carcinoma of the anal canal is the focus of current studies.

60 Mean functional anal canal length was 3.4 0.5 cm (range: 2.4-4.8 mm).

61 CP) were: resting (mean pressure, functional anal canal length); short squeeze (mean and maximum abso

62 Functional anal-canal length varied after the operation from 3.3 cm

63 bococcygeal muscles were noted in 32% at the anal canal level, in 49% at the perineal body level, and

64 human papillomavirus (HPV) infection in the anal canal, little attention has been paid to the epidem

65 All patients had a proximal anal canal mucosal excision and a hand-sewn anastomosis

66 HPV DNA was found in the anal canal of 57% of study participants.

67 Exfoliated cells from the anal canal of 902 MSW in Brazil (Sao Paulo), Mexico (Cue

68 ce of HR-HPV types, including HPV-16, in the anal canal of HIV-positive women is concerning.

69 During evacuation, the anal canal opened and evacuation occurred.

70 pressure device placed within the vagina or anal canal, or electromyographic (EMG) sensors in the sa

71 Anal canal pressure and EAS length-tension (L-T) were me

72 he EAS resulted in significant impairment in anal canal pressure and EAS muscle L-T function.

73 Resting anal canal pressures were higher in the patients who und

74 patient age, symptom severity, pretreatment anal canal pressures, and results of anal ultrasonograph

75 ugh (anal canal and rectum maximum pressure, anal canal PV); push (anal canal and rectum maximum pres

76 tion percent); recto-anal inhibitory reflex (anal canal relaxation percent).

77 ssure); push (rectum-anal gradient pressure, anal canal relaxation percent); recto-anal inhibitory re

78 Anal canal relaxation was higher in women (push).

79 Despite the rarity of carcinoma of the anal canal, remarkable progress has been achieved during

80 New drugs are needed that target anal canal resting pressure in fecal incontinence and hy

81 Increases in anal canal resting pressure may also contribute to impro

82 Squamous cell carcinoma of the anal canal (SCCA) is a rare malignancy associated with i

83 sociated with squamous cell carcinoma of the anal canal (SCCA).

84 Purpose Squamous cell carcinoma of the anal canal (SCCAC) is characterized by high locoregional

85 Purpose Squamous cell carcinoma of the anal canal (SCCAC) is characterized by high locoregional

86 us, penile shaft/prepuce, scrotal, perianal, anal canal, semen, and urine samples were obtained.

87 Fissures, fistulas, abscesses, and anal canal stenosis are manifestations of perianal Crohn

88 In the presence of both colonic disease and anal canal stenosis, the OR associated with permanent st

89 Anal canal stimulation resulted in activation of areas s

90 ression, the presence of colonic disease and anal canal stricture were predictors of permanent divers

91 s having T2N3 squamous cell carcinoma of the anal canal (Table 1).

92 es possess two diagonally opposed endodermal anal canals that open at the base of the apical organ.

93 provided an overview of the carcinoma of the anal canal, the role of screening, advancements in radia

94 nd rectum ranging from a minimally displaced anal canal to a complete fusion of the anorectum, vagina

95 r GTN or placebo) to be applied to the lower anal canal twice daily.

96 Anal canal was harvested and processed for histochemical

97 ologists and the pathologist agreed that the anal canal was involved.

98 Transvaginal US of the anal canal was performed in 28 women (aged 27-74 years)

99 To improve on intraluminal imaging of the anal canal, we conducted a first-in-human study to deter